National Health Investors, Inc.: 10-Q filed 2015-11-05
What National Health Investors, Inc. reported in its quarterly report filed 2015-11-05 (fiscal Q3 2015): 27 published measures, 80 facts as tagged in accession 0000877860-15-000087.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-11-05
- Fiscal period
- fiscal Q3 2015
- Accession
- 0000877860-15-000087 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All National Health Investors, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 2,133,125,000 | USD | |
| At 2014-12-31 | 1,982,960,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,088,459,000 | USD | |
| At 2014-12-31 | 933,027,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,034,904,000 | USD | |
| At 2014-12-31 | 1,039,925,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 14,197,000 | USD | |
| At 2015-03-31 | 14,197,000 | USD | |
| At 2014-12-31 | 3,287,000 | USD | |
| At 2014-03-31 | 3,559,000 | USD | |
| At 2013-12-31 | 11,312,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 33,600,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 94,466,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 25,250,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 74,080,000 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 120,796,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 93,215,000 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 58,282,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 170,346,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 44,478,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 131,775,000 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 48,860,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | -54,491,000 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | -158,746,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | -46,477,000 | USD | 273 |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 37,566,221 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 37,563,503 | shares | 273 |
| 2014-07-01 to 2014-09-30 | 33,055,992 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 33,053,386 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 37,583,141 | shares | 92 |
| 2015-01-01 to 2015-09-30 | 37,611,841 | shares | 273 |
| 2014-07-01 to 2014-09-30 | 33,088,570 | shares | 92 |
| 2014-01-01 to 2014-09-30 | 33,087,029 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 0.89 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | 2.51 | USD/shares | 273 |
| 2014-07-01 to 2014-09-30 | 0.76 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | 2.24 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 0.89 | USD/shares | 92 |
| 2015-01-01 to 2015-09-30 | 2.51 | USD/shares | 273 |
| 2014-07-01 to 2014-09-30 | 0.76 | USD/shares | 92 |
| 2014-01-01 to 2014-09-30 | 2.24 | USD/shares | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,843,213,000 | USD | |
| At 2014-12-31 | 1,776,549,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 1,930,000 | USD | 273 |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 9,772,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 27,471,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 7,005,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 20,720,000 | USD | 273 |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 4,633,000 | USD | |
| At 2014-12-31 | 3,818,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 25,179,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 75,179,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 18,909,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 56,980,000 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 37,566,221 | shares | |
| At 2014-12-31 | 37,485,902 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 875,000 | USD | |
| At 2014-12-31 | 6,223,000 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,044,666,000 | USD | |
| At 2014-12-31 | 1,049,933,000 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 2,088,622,000 | USD | |
| At 2014-12-31 | 1,988,849,000 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 245,409,000 | USD | |
| At 2014-12-31 | 212,300,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 33,103,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 95,167,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 25,569,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 74,795,000 | USD | 273 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 33,977,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 95,528,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 25,516,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 74,952,000 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 29,920,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 89,118,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 26,335,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 71,651,000 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 1,691,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 8,050,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 2,164,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 6,948,000 | USD | 273 |
Inspect the source
- Entity
- National Health Investors, Inc. / CIK 0000877860
- Captured
- 2026-09-20T05:01:19.323Z
- SEC response SHA-256
800d4eb06d8d005c13461b54ffacc4cde98eabd76680f56a43c825e171984500
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000877860.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))